Investing RAD receives IND approval from US FDA for Betabart (RV-01) July 28, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Asara raises $25m to accelerate exploration at Kada July 28, 2025 Next Post S&P 500 Breaking Out Again: What This Means for Your Portfolio July 28, 2025 Related Posts Canada One Provides Exploration Review of Boundary Zone, Copper Dome Project November 6, 2025 Goldgroup Mining November 6, 2025 LaFleur Minerals Advances Swanson Confirmation Drilling to Support Beacon Mill Restart and PEA November 6, 2025
LaFleur Minerals Advances Swanson Confirmation Drilling to Support Beacon Mill Restart and PEA November 6, 2025